MethylGene vs Oryzon Genomics SA
MethylGene is the older company (1997 vs 2000).
Side-by-Side Comparison
| Metric | MethylGene | Oryzon Genomics SA |
|---|---|---|
| Founded | ||
| Founded | 1997 older | 2000 |
| Headquarters | ||
| Headquarters | Not tracked yet | Spain |
| Employees | ||
| Employees | Not tracked yet | 60 |
| Industry | ||
| Industry | Biopharma, Biotechnology | Not tracked yet |
| Funding Stage | ||
| Funding Stage | Venture round | IPO |
| Total Funding | ||
| Total Funding | $71.83M | $193.19M |
| Funding Rounds | ||
| Funding Rounds | 4 | 21 |
| Services | ||
| Services | Not tracked yet | Development of personalized therapeutics, Epigenetic biomarker identification, Innovation in cancer and CNS disorder treatments, Patent portfolio management |
| Target Customers | ||
| Target Customers | Not tracked yet | Patients with cancer, Patients with CNS disorders, Healthcare providers, Biopharmaceutical investors |
| Taxonomy | ||
| Taxonomy | Biopharmaceutical CompanyClinical StageCancer TherapeuticsKinase InhibitorsHDAC InhibitorsOncology +8 | Personalized MedicineEpigeneticsCNS DisordersOncologyBiopharmaceuticalsLSD1 Inhibitors +9 |
| Website | ||
| Website | methylgene.com | oryzon.com |
About MethylGene
MethylGene is a clinical stage biopharmaceutical company dedicated to the development and commercialization of innovative therapeutics primarily targeting cancer. Founded in 1997, it trades on the public market under the symbol TSX:MYG. The company's product portfolio includes MGCD265, an oral, mult...
About Oryzon Genomics SA
Oryzon Genomics SA, founded in 2000 and headquartered in Spain, is a clinical stage biopharmaceutical leader in the development of epigenetics-based therapeutics, with an emphasis on personalized medicine for CNS disorders and oncology. Known for its slogan, "Pioneering personalized medicine in epig...
Also comparing in this category
Comparing more than these two?
Get MethylGene, Oryzon Genomics SA and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.
How does MethylGene compare?
A PDF of MethylGene and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Rival Readout
Comparing competitors? We do this properly.
10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.
Frequently Asked Questions
Compare MethylGene with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at MethylGene on 19 Jun 2024, and Oryzon Genomics SA on 26 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
